Healthcare >> CEO Interviews >> January 25, 2010
Dr. Michael Fonstein, Ph.D., has served as Cleveland BioLabs' Chief Executive Officer and President, and as a Director since the company's inception in June 2003. Prior to this, he served as Director of the DNA Sequencing Center at the University of Chicago from its creation in 1994 to 1998, when he left to found Integrated Genomics, Inc., located in Chicago, Illinois. He served as CEO and President of Integrated Genomics from 1997 to 2003. Dr. Fonstein has won several business awards, including the Incubator of the Year Award from the Association of University Related Research Parks. He was also the winner of a coveted KPMG Illinois High Tech Award. Profile
TWST: You have two families of drugs, correct? One is Curaxins, anti-cancer drugs that don't use chemotherapy?
Dr. Fonstein: Yes.
TWST: The others are Protectans, which are designed to keep healthy
